Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VKTX
VKTX logo

VKTX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VKTX News

Truist Initiates Coverage on VKTX with Buy Rating and $83 Price Target

1d agostocktwits

Obesity Drug Market Poised for Growth

3d agoFool

Weight Loss Drug Market Poised for Growth

3d agoNASDAQ.COM

Viking Therapeutics Faces Competitive Pressures

4d agoNASDAQ.COM

Viking Therapeutics Stock Plummets, Future Uncertain

4d agoFool

Eli Lilly's Dominance in Weight Loss Drug Market

4d agoNASDAQ.COM

Eli Lilly's Breakthrough Weight Loss Drug Trial Success

4d agoFool

Viking Therapeutics Emerges as Potential Acquisition Target in Biotech

6d agoFool

Viking Therapeutics Emerges as Potential Acquisition Target for Big Pharma

6d agoNASDAQ.COM

Analysis of Biotech Companies' Prospects

May 22 2026NASDAQ.COM

Investment Potential Analysis of Biotech Stocks

May 22 2026Fool

Viking Therapeutics: A Potential New Star in Weight Loss Drugs

May 21 2026Fool

Eli Lilly's Dominance in Weight Loss Drug Market

May 21 2026NASDAQ.COM

Viking Therapeutics to Participate in Two Major Healthcare Conferences

May 21 2026PRnewswire

Viking Therapeutics to Participate in Two Major Healthcare Conferences

May 21 2026Newsfilter

Intense Competition in Weight-Loss Drug Market

May 21 2026NASDAQ.COM